
Vitamin D supplements may help slow down aging by 3 years
One study found that vitamin D supplementation helps to minimize the shortening of telomeres, which happens as people get older, and thus may protect against diseases tied to age and biological aging.
This data adds to the potential protective components of vitamin D, which experts should consider alongside potential risks and additional research.
As the authors of this study explained, telomeres help protect the ends of chromosomes. Telomere shortening might increase the risk of death and certain diseases.
David Cutler, MD, a board certified family medicine physician at Providence Saint John's Health Center in Santa Monica, CA, who was not involved in the study, told Medical News Today that 'When telomeres become too short, cells enter senescence (a non-dividing state) or apoptosis (programmed cell death). Either condition of cell inactivity or death is thought to contribute to aging and age-related diseases.'
The researchers found that vitamin D supplementation helped minimize telomere shortening in white blood cells, which could help slow down biological aging.
For this study, researchers used data from the VITAL trial. This trial included a representative sample of adults in the United States who received vitamin D3 supplements, omega-3 fatty acid supplements, or both for around five years. It was a double-blind, placebo-controlled study, so some participants received the supplements while others received the placebo. All female participants were at least fifty-five years old, and all male participants were at least fifty.
This data specifically examined a cohort that visited the Harvard Clinical and Translational Science Centre. At baseline and follow-up visits, participants participated in in-person assessments and provided fasting blood samples.
Researchers examined telomere length in leukocytes , which are the body's white blood cells, among participants who received supplements and those who received the placebo.
Researchers were able to analyze over 2,500 samples from over 1,000 participants. They examined telomere length at baseline and at two- and four-year follow-up, though some data was missing.
They conducted a statistical analysis using models to adjust for various covariates. They also did an exploratory subgroup analysis to see how different factors, such as high blood pressure and diabetes, impacted results.
Aside from a higher body mass index in the omega-3 fatty acid supplement group, the placebo and intervention groups had similar baseline characteristics. Missing data was also similar between the two groups.
Vitamin D appeared to have a positive impact on telomere length. Among participants who received vitamin D, there was only minimal shortening of telomere length at two and four years. In contrast, there was substantial telomere shortening in the placebo group at both time points.
Omega-3 fatty acids supplementation appeared to have no significant impact on telomere length.
The subgroup analysis further suggested that the effects of vitamin D on telomere length were significant for participants not taking medication for cholesterol, but not for participants who were taking cholesterol medication. Vitamin D also minimized telomere shortening at a statistically significant level for non-white participants.
There was no significant interaction with body mass index, but researchers did observe that participants who were not obese had significantly minimized telomere shortening. Also, taking omega-3 fatty acid supplements did not appear to impact the role of vitamin D on telomere length.
This analysis of telomere length in this study population does have some limitations. First, most participants were white, and all participants were at least fifty, so it may not be possible to generalize the findings to other groups.
Researchers acknowledge that this was a post-hoc analysis of an already completed study and that the study was not originally designed to look at the effects of supplements on leukocyte telomere length. The analysis also excluded participants who did not have data on leukocyte telomere length.
It's possible that unaccounted-for factors influenced the results, and the study also has any other limitations found in the original study.
Regarding exploratory subgroup analysis results, researchers encourage caution, note limited power, and say people should look at the data as 'hypothesis-generating.'
After four years, there were about 37% missing cases. Researchers acknowledge that this reduced power and could be why they did not find omega-3 fatty acid supplementation affected leukocyte telomere length.
Future research can explore why vitamin D may have these effects on telomere length. For example, it could be related to an enzyme called telomerase that helps to lengthen telomeres and how vitamin D may protect against DNA damage.
Cutler also noted the following limitations of the study:
'The present study involved only a relatively small number of people, looked only at telomeres in white blood cells, and did not look extensively at the health impact of these telomere changes. So, the clinical implications one can derive from this study are quite limited.'
This study suggests the potential benefits of vitamin D in relation to aging. The authors suggest that the preservation of telomere length in this study 'could mean a 3-year decrease in aging.'
'As we know already, vitamin D supports bone, immune system and reduces inflammation, but this study is linked directly with telomere preservation which ties into aging and disease prevention. This [study] gives more of a general idea that vitamin D3 could do more than just helping your bones but actually slowing down the cellular age, impressive!'
'If this is confirmed in future studies, this could mean that daily [vitamin D} supplements could actually help reduce risks for age-related diseases. This is a door for new medical guidelines in the future and will be a huge deal for preventive medicine.'
— Yoshua Quinones, MD
However, it's also important to note the potential risks of vitamin D supplementation.
'While 2,000 units of vitamin D is unlikely to have any negative effects, there may be some risk to vitamin D supplements as they can cause kidney damage and other adverse effects in excessive quantities. Since vitamin D is fat soluble, it can accumulate in our bodies, causing toxicity. So, any potential, as yet unproven benefits of vitamin D need to be weighed against its known risks,' Cutler said.
Supplements
Nutrition / Diet
Seniors / Aging
antiaging
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
15 minutes ago
- Reuters
Comic-Con: 'Tron: Ares' digital and real worlds collide
SAN DIEGO, July 25 (Reuters) - The real and virtual worlds collided on Friday in clips from Disney's "Tron: Ares" movie, as fans got a preview of high-speed, high-tech motorcycle scenes at Comic-Con in San Diego. "I'm an official 'Tron' super fan," said Jared Leto, who stars as Ares, a hyper-intelligent program sent from the virtual to the real world, presenting a new threat to humans from artificial intelligence. "Movies like this really gave me something to dream for and about," Leto told a panel discussion after red and blue laser lights and people in glowing high-tech outfits filled Hall H at the convention. The "Suicide Squad" actor said he had latched onto the original "Tron" film as a lover of video games when he was young. "Tron: Ares" is the third installment in the series dating back to 1982 and a sequel to the 2010 movie "Tron: Legacy." Jeff Bridges, who was also on the panel, will be reprising his role as the computer hacker Kevin Flynn in the science fiction thriller, which arrives in theaters on October 10. "Pixels definitely have more fun," said Cameron Monaghan, comparing his role as a computer program to portraying a human being.


The Independent
44 minutes ago
- The Independent
California doctor sued for ‘wrongful death' after shipping abortion drugs interstate in legal first
A Texas man is suing a doctor in California he claims mailed his girlfriend pills to end her pregnancy - in what may be a legal first - and a test of new state abortion laws. Jerry Rodriguez filed a wrongful death lawsuit against Remy Coeytaux, after the doctor sent the abortion-inducing drugs across state lines in order to 'murder his unborn son,' Rodriguez claimed. It appears to be the first time an interstate lawsuit for wrongful death over an abortion has been filed, according to The Washington Post. In Texas, a person who assists a pregnant woman in obtaining a self-managed abortion commits the crime of murder and can be sued for wrongful death, the lawsuit, filed in Texas federal court and obtained by The Independent, states. The woman herself cannot be prosecuted. The suit adds it is also a state jail felony for anyone other than a Texas-licensed physician to provide an abortion-inducing drug for the purpose of inducing an abortion. 'In violation of these and many other laws, defendant Remy Coeytaux mailed abortion-inducing drugs into Texas that were used to murder Jerry Rodriguez's unborn child,' the complaint reads. Rodriguez is suing Coeytaux for $75,000 over what he claims is wrongful death. He's also seeking an injunction to stop the doctor from distributing abortion-inducing drugs in violation of state or federal law. The injunction, the suit states, is being sought 'on behalf of a class of all current and future fathers of unborn children in the United States.' But such state legislation clashes with that of California, which retains a so-called 'Shield Law' to protect medical professionals such as Coeytaux. The law provides that 'California will not deliver a person accused or charged with committing a crime related to abortion/gender-affirming care over to law enforcement officials.' This includes situations where a California-licensed pharmacist dispenses an abortion-inducing drug mifepristone to a patient in a state with abortion-restrictive laws. According to Rodriguez's suit, he began dating his girlfriend in June 2024, while she was separated from her husband, but not yet divorced. The Independent has chosen not to name the woman, due to privacy reasons and because she is not a defendant in the lawsuit. The suit alleges that the woman's husband, Adam Garza, twice ordered the abortion medication from Coeytaux after she became pregnant by Rodriguez 'with the intent of using them to murder Mr. Rodriguez's unborn child,' and 'pressured her' to take the pills. A Venmo receipt confirming Garza's purchase of the drugs from Coeytaux was included in the lawsuit, with a reference of ''Aed axes' – allegedly a homonym for 'Aid Access,' an organization that ships abortion-inducing drugs into jurisdictions where abortion is not legal. 'Defendant Coeytaux caused the death of Mr. Rodriguez's unborn child through his wrongful acts,' the lawsuit states. 'Although [the woman] cannot be charged with murder for her role in killing her unborn child, her immunity does not shield Coeytaux from liability for aiding or abetting or directly participating in the murder.' 'Mr. Rodriguez seeks this injunction on behalf of a class of all current and future fathers of unborn children in the United States.'


Reuters
an hour ago
- Reuters
'Predator: Badlands' propels predator perspective at Comic-Con
SAN DIEGO, July 25 (Reuters) - The latest movie in the "Predator" series flips the script to focus on the bad guys who always lose to the humans in the end, director Dan Trachtenberg said on Friday. "The predator never wins," Trachtenberg told an audience at San Diego Comic-Con after footage of "Predator: Badlands" debuted at the convention's Disney panel. This, the "Prey" director said, inspired him to tell the story from the predator species perspective in "Badlands," the seventh in the main movie series, dating back to the 1987 hit starring Arnold Schwarzenegger, and the ninth across the franchise. It was key, Trachtenberg said, for him to explore a different aspect of the "Predator" world for this science fiction movie, developed by 20th Century Studios and landing in theaters on November 7. "There are no humans in this film," said cast member Elle Fanning, discussing the challenges of learning the logistics of a completely fictional realm. The biggest challenge was mastering the fictional Yautja language, said Dimitrius Schuster-Koloamatangi, who stars as Dek, a young predator on a solo mission in a treacherous land of even bigger predators. He bonds with an android named Thia, played by Fanning. Dek is "ferocious and badass, very much an anti-hero," Trachtenberg said. Before the panel discussion with the director and several cast members, the audience got a glimpse of a Yautja-speaking predator prowling the stage with the signature glowing weaponry as stirring music played.